The SMILE Study

 

The goal of the study is to demonstrate a significant decrease in the rate of Heart Failure (HF) re-hospitalizations based on ReDS-SensiVest™ directed  treatment as an adjunct to standard of care during the entire randomized follow-up period.

To learn more about the SMILE Study design please visit ClinicalTrials.gov

 

Sensible Medical Innovations lung fLuid status monitor
allows rEducing readmission rate of heart failure patients

JOIN THE STUDY AS A PATIENT

If you suffer from Heart Failure, please ask your physician about the study.

JOIN THE STUDY AS A SITE

Email the SMILE team at: SMILE@sensible-medical.com

 

or contact :

Dr. Ronnie Abbo, MD                                  Marci Mishkin

Chief Medical Officer                                       Director US Clinical Operations

ronnie.a@sensible-medical.com                    marci.m@sensible-medical.com